KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 19 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,388,000 | +3.6% | 9,900,000 | 0.0% | 0.22% | +5.8% |
| Q4 2021 | $8,093,000 | +53.6% | 9,900,000 | +41.4% | 0.21% | +37.1% |
| Q3 2021 | $5,268,000 | -25.0% | 7,000,000 | 0.0% | 0.15% | -23.4% |
| Q2 2021 | $7,021,000 | +65.2% | 7,000,000 | +70.7% | 0.20% | +28.8% |
| Q1 2021 | $4,249,000 | -17.7% | 4,100,000 | 0.0% | 0.15% | -15.5% |
| Q4 2020 | $5,164,000 | +5.3% | 4,100,000 | 0.0% | 0.18% | +1.7% |
| Q3 2020 | $4,902,000 | -14.7% | 4,100,000 | 0.0% | 0.18% | -30.5% |
| Q2 2020 | $5,746,000 | -2.2% | 4,100,000 | 0.0% | 0.26% | +29.9% |
| Q1 2020 | $5,876,000 | -31.5% | 4,100,000 | -31.7% | 0.20% | +35.9% |
| Q4 2019 | $8,576,000 | – | 6,000,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 8,000,000 | $5,215,000 | 9.09% |
| BRAIDWELL LP | 65,976,000 | $40,943,996 | 1.29% |
| Context Capital Management, LLC | 21,494 | $13,329 | 1.07% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,500,000 | $20,663,750 | 0.86% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $15,264,731 | 0.24% |
| DeepCurrents Investment Group LLC | 4,250,000 | $2,700,994 | 0.12% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,500,000 | $4,654,419 | 0.02% |
| Verition Fund Management LLC | 1,359 | $843,381 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 6,500,000 | $4,033 | 0.01% |
| BLB&B Advisors, LLC | 75,000 | $45,794 | 0.00% |